The challenge of managing patients with light-chain cardiac amyloidosis: the value of cardiac magnetic resonance as a guide to the treatment response
- PMID: 36269640
- DOI: 10.1093/eurheartj/ehac526
The challenge of managing patients with light-chain cardiac amyloidosis: the value of cardiac magnetic resonance as a guide to the treatment response
Conflict of interest statement
Conflict of interest: T.D. reports grants and/or personal fees from Alnylam, Ionis, Janssen, Neurimmune, and Pfizer.
Comment on
-
Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment.Eur Heart J. 2022 Dec 1;43(45):4722-4735. doi: 10.1093/eurheartj/ehac363. Eur Heart J. 2022. PMID: 36239754 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical